Showing results (1481-1490 of 1,499) with videos related to
Sort By:
Pageof 150
Nature Nanotechnology|July 20, 2023
Oriented lateral growth of two-dimensional materials on c-plane sapphireJui-Han Fu, Jiacheng Min, Che-Kang Chang, et al.Frontiers in Immunology|October 5, 2020
CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized MiceZhisheng Her, Joel Heng Loong Tan, Yee-Siang Lim, et al.ACS Nano|February 24, 2026
Bismuth Confinement: A Strategy for Low Resistance and Good Thermal Endurance of Integrated Contacts to MoS2Wen-Chia Wu, Terry Y T Hung, Fu-Kuo Hsueh, et al.Cancer Cell|November 3, 2009
AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistanceThomas O'Hare, William C Shakespeare, Xiaotian Zhu, et al.Journal of Personalized Medicine|November 27, 2021
High Skin Sympathetic Nerve Activity in Patients with Recurrent SyncopeTien-Chi Huang, Nai-Yu Chi, Chih-Sung Lan, et al.Bioorganic & Medicinal Chemistry Letters|May 13, 2011
Discovery of 5-(arenethynyl) hetero-monocyclic derivatives as potent inhibitors of BCR-ABL including the T315I gatekeeper mutantMathew Thomas, Wei-Sheng Huang, David Wen, et al.BMC Plant Biology|December 1, 2022
OrchidBase 5.0: updates of the orchid genome knowledgebaseYou-Yi Chen, Chung-I Li, Yu-Yun Hsiao, et al.BMC Plant Biology|January 3, 2025
OrchidBase 6.0: increasing the number of Cymbidium (Orchidaceae) genomes and new bioinformatic tools for orchid genome analysisYou-Yi Chen, Ye Sun, Chung-I Li, et al.Journal of Medicinal Chemistry|May 5, 2016
Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma KinaseWei-Sheng Huang, Shuangying Liu, Dong Zou, et al.Nature Communications|June 26, 2021
Population genomics of apricots unravels domestication history and adaptive eventsAlexis Groppi, Shuo Liu, Amandine Cornille, et al.Pageof 150